Q&A: What the transition away from animal testing could mean for drug discovery
In September, the U.S. Senate unanimously passed the FDA Modernization Act 2.0, which would lift an 84-year-old federal mandate for animal testing for toxicity studies. While the bill doesn’t ban animal testing outright, it would allow drug developers to use alternatives when feasible.
To learn more about these alternatives, Drug Discovery & Development spoke with Susan Murphy, President of Molecular Devices, which works to enable high-throughput organoid research for life scientists.